leadf
logo-loader
NASDAQ:SNGX

Soligenix

Receive alerts
Market:
NASDAQ
Market Cap:
$68.35 m
Price
2.29 USD
Change
-0.87%
52 weeks high
3.50
52 weeks low
0.99

In brief

Soligenix, Inc. is a late-stage research and development biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatment and serious gastrointestinal diseases where there remains an unmet medical need, as well as developing biodefense vaccines and therapeutics.